Lorenzo D'ambrosio
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].
Journal: Critical reviews in oncology/hematology
Published: June 27, 2026
17β-Estradiol Modulates Cancer Cell-Fibroblast Communication via Autophagy-Mediated Extracellular Vesicle Secretion and Promotes Poor Prognosis in Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: June 25, 2026
Management of atypical cartilaginous tumors (ACT): an Italian Sarcoma Group (ISG) consensus document.
Journal: Critical reviews in oncology/hematology
Published: March 04, 2026
Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC.
Journal: Journal for immunotherapy of cancer
Published: January 11, 2026
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 24, 2025
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma.
Journal: Journal of translational medicine
Published: September 10, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Journal: Cancer treatment reviews
Published: June 13, 2025
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group.
Journal: Critical reviews in oncology/hematology
Published: May 18, 2025
Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC.
Journal: Journal for immunotherapy of cancer
Published: May 01, 2025
Editorial: The immune infiltrate as a paradigm model to study the biology and novel therapeutic approaches in sarcomas, volume II.
Journal: Frontiers in endocrinology
Published: April 28, 2025
The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes.
Journal: Cancer immunology, immunotherapy : CII
Published: April 16, 2025
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors.
Journal: JAMA network open
Published: January 24, 2025
Last Updated: 09/26/2026